Radiological Protection Ordinance
(RPO)

English is not an official language of the Swiss Confederation. This translation is provided for information purposes only and has no legal force.

of 26 April 2017 (Status as of 1 January 2022)


Open article in different language:  DE  |  FR  |  IT
Art. 48 Expert Commission for Radiopharmaceuticals

1 The Ex­pert Com­mis­sion for Ra­dio­phar­ma­ceut­ic­als (ECRP) is a stand­ing ad­vis­ory com­mis­sion with­in the mean­ing of Art­icle 8a para­graph 2 of the Gov­ern­ment and Ad­min­is­tra­tion Or­gan­isa­tion Or­din­ance of 25 Novem­ber 199827 (GAOO).

2 It shall ad­vise the Fed­er­al De­part­ment of Home Af­fairs (FDHA), Swiss­med­ic and the FOPH on ra­dio­phar­ma­ceut­ic­al mat­ters. In par­tic­u­lar, it has the fol­low­ing tasks:

a.
it pre­pares re­ports on ap­plic­a­tions for the mar­ket­ing au­thor­isa­tion of ra­dio­phar­ma­ceut­ic­als;
b.
it pre­pares re­ports on safety-re­lated ques­tions con­nec­ted with ra­dio­phar­ma­ceut­ic­als;
c.
it ad­vises the FH­HA on the amend­ment of An­nex 1 to the Thera­peut­ic Products Or­din­ance of 21 Septem­ber 201828.29

It is com­prises spe­cial­ists from the fields of nuc­le­ar medi­cine, phar­ma­ceut­ics, chem­istry and ra­di­olo­gic­al pro­tec­tion.

27 SR 172.010.1

28 SR 821.212.21

29 Amended by An­nex 6 No II 4 of the Thera­peut­ic Products Or­din­ance of 21 Sept. 2018, in force since 1 Jan. 2019 (AS 2018 3577).

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Laden